View Author

Graeff-Meeder, E.R. de

( E.R. de Graeff-Meeder)


children patient therapy indinavir month infection count study adherence 6 months range immunodeficiency virus infection virus value baseline plasma pediatrics adult immunodeficiency result treatment zidovudine combination inhibitor antiretroviral therapy response center lamivudine medication antiretroviral level plasma hiv reference value month 6 limit reference <500 copies /ml group virologic change disease curve pharmacokinetic immunodeficiency virus 3 months hospital protease rna load analysis problem protease inhibitor indinavir p i e / m l <40 copies /ml event growth pretreated patients hiv infection system trial time points increase department combination therapy 1 month virologic response deviation netherland reduction capsule relation 2 patients 2 reverse-transcriptase inhibitors medication diaries 40 copies /ml 2 weeks blood cell count adult values protease inhibitor haart




1 Most Recent Publications

Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: A multicenter study in The Netherlands. (Article)
Rossum, A.M.C. van Geelen, S.P.M. Burger, D.M. Hop, W.C.J. Niesters, H.G.M. Groot, R. de Scherpbier, H.J. Hartwig, N.G. Weemaes, C. Veerman, A.J.P. Suur, M.H. Graeff-Meeder, E.R. de Slieker, W.A.T. Osterhaus, A.D.M.E.
2000-01-01